Lack of CD45 expression has a strong prognostic value in patients with multiple myeloma receiving high-dose therapy

被引：0
|
作者：
Moreau, P
Robillard, N
Avet-Loiseau, H
Morineau, N
Pineau, D
Milpied, N
Mahé, B
Vigier, M
Rapp, MJ
Harousseau, JL
Bataille, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [1] Lack of CD45 expression has a strong prognostic value in patients with multiple myeloma (MM) receiving high-dose therapy (HDT).
    Moreau, P
    Robillard, N
    Avet-Loiseau, H
    Pineau, D
    Morineau, N
    Milpied, N
    Mahe, B
    Rapp, MJ
    Harousseau, JL
    Bataille, R
    BLOOD, 2002, 100 (11) : 810A - 810A
  • [2] Patients with CD45 negative multiple myeloma receiving high-dose therapy have it shorter survival than those with CD45 positive multiple myeloma
    Moreau, P
    Robillard, N
    Avet-Loiseau, H
    Pineau, D
    Morineau, N
    Milpied, N
    Harousseau, JL
    Bataille, R
    HAEMATOLOGICA, 2004, 89 (05) : 547 - 551
  • [3] Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
    Kumar, S
    Gertz, MA
    Dispenzieri, A
    Lacy, MQ
    Wellik, LA
    Fonseca, R
    Lust, JA
    Witzig, TE
    Kyle, RA
    Greipp, PR
    Rajkumar, SV
    BONE MARROW TRANSPLANTATION, 2004, 34 (03) : 235 - 239
  • [4] Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
    S Kumar
    M A Gertz
    A Dispenzieri
    M Q Lacy
    L A Wellik
    R Fonseca
    J A Lust
    T E Witzig
    R A Kyle
    P R Greipp
    S V Rajkumar
    Bone Marrow Transplantation, 2004, 34 : 235 - 239
  • [5] Gene expression profiles as prognostic factors for high-dose therapy and bortezomib in patients with multiple myeloma
    Broyl, A.
    Hose, D.
    de Knegt, Y.
    Lokhorst, H.
    Goldschmidt, H.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 257 - 257
  • [6] Gene expression profiles as prognostic factors for high-dose therapy and bortezomib in patients with multiple myeloma
    Broyl, A.
    Hose, D.
    De Knegt, Y.
    Lokhorst, H.
    Goldschmidt, H.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 65 - 65
  • [7] High-dose therapy in multiple myeloma
    Harousseau, JL
    ANNALS OF ONCOLOGY, 2002, 13 : 49 - 54
  • [8] High-dose therapy in multiple myeloma
    Dimopoulos, MA
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 142 - 143
  • [9] The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma
    Gonsalves, Wilson I.
    Timm, Michael M.
    Rajkumar, S. Vincent
    Morice, William G.
    Dispenzieri, Angela
    Buadi, Francis K.
    Lacy, Martha Q.
    Dingli, David
    Leung, Nelson
    Kapoor, Prashant
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji K.
    LEUKEMIA RESEARCH, 2016, 44 : 32 - 39
  • [10] Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis
    时杰
    China Medical Abstracts(Internal Medicine), 2019, 36 (04) : 229 - 230
12345